↓ Skip to main content

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#38 of 2,910)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
15 news outlets
twitter
62 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
312 Dimensions

Readers on

mendeley
272 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Published in
Journal for Immunotherapy of Cancer, July 2019
DOI 10.1186/s40425-019-0662-5
Pubmed ID
Authors

Ezra E. W. Cohen, R. Bryan Bell, Carlo B. Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh-Thu Le, Nancy Y. Lee, Rom Leidner, Rebecca L. Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris

Twitter Demographics

The data shown below were collected from the profiles of 62 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 272 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 272 100%

Demographic breakdown

Readers by professional status Count As %
Other 30 11%
Student > Ph. D. Student 29 11%
Researcher 29 11%
Student > Bachelor 26 10%
Student > Doctoral Student 18 7%
Other 49 18%
Unknown 91 33%
Readers by discipline Count As %
Medicine and Dentistry 94 35%
Biochemistry, Genetics and Molecular Biology 29 11%
Agricultural and Biological Sciences 14 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Immunology and Microbiology 6 2%
Other 23 8%
Unknown 99 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 149. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2022.
All research outputs
#229,226
of 22,780,967 outputs
Outputs from Journal for Immunotherapy of Cancer
#38
of 2,910 outputs
Outputs of similar age
#4,977
of 345,066 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 88 outputs
Altmetric has tracked 22,780,967 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,910 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,066 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.